DE GEUS AART

De Geus sells 15,705 SNPS shares at $444.42; prior 5 trades at ticker 100% well-timed (90d -14.9% to -21.1%)

De Geus sold 15.7K shares on 2025-03-06 at $444.42, reducing his holdings by 11.9% from 132.4K to 116.7K shares for $7.0M. This sale follows a striking pattern: his 5 prior open-market sales at SNPS (July 2024) were all well-timed, with 90-day returns ranging from -14.9% to -21.1%, meaning the stock declined after each sale. His cross-ticker track record also shows strong timing acumen, with a 90-day well-timed rate of 80.00% across 15 prior sells. Currently, SNPS is down 30.8% from its 52-week high of $621.30 and has declined 18.2% over 30 days, suggesting material price deterioration since the March sale. The consistency of well-timed sells at this specific ticker merits investor attention, as it points to systematic advantage in recognizing inflection points rather than routine portfolio rebalancing.

Executive Chair de Geus sells 13.2K SNPS shares for $8.2M in 2 transactions at $620.77 average

De Geus sold 13,236 shares across two transactions on 2024-07-10 and 2024-07-11 for a blended average price of $620.77, representing an 11.0% reduction in his 120,219 pre-transaction holdings. The sales occurred near the 52-week high of $621.30, with the stock currently at $614.05. This filing is part of a pattern: de Geus has executed 5 sells at SNPS in the prior week (2024-07-01 through 2024-07-08), all with outcomes not yet measurable. His cross-ticker track record across 13 prior open-market sells shows an average 90-day return of +4.7% and a 90-day well-timed rate of 0.00%, indicating his prior sales did not precede declines. The timing context here is factual: the executive sold at prices very near the recent peak, though without additional information about the motivations or structure of these trades (such as the presence of a 10b5-1 plan), the significance remains moderate.

Executive Chair Aart de Geus sells 33,201 shares in 2 transactions for $20,550,399.23; holds 106,983 shares post-sale.

De Geus executed two separate sales on 2024-07-05 and 2024-07-08, disposing of 33,201 shares at a blended average price of $618.97 and reducing his holding by 23.7% from 140,184 to 106,983 shares. This represents a substantial reduction in position size at prices near the 52-week high of $621.30, occurring within a 4-week window that included earlier sales on 2024-06-27, 2024-06-28, 2024-07-01, 2024-07-02, and 2024-07-03 at the same ticker. De Geus's cross-ticker track record shows 11 prior sells with a 0.00% well-timed rate at the 90-day mark, suggesting his sell timing has historically not preceded subsequent declines. The repetitive nature of these sales in rapid succession merits investigation to determine whether they are driven by discretionary decisions or pre-scheduled under a Rule 10b5-1 trading plan.

SNPS Executive Chair sold 7,129 shares in 2 transactions for $4,352,409.81 on Jul 2-3, retaining 106,983 shares.

De Geus, Executive Chair of Synopsys, executed 2 separate sales totaling 7,129 shares for $4,352,409.81, reducing his holdings by 6.2% to 106,983 shares. The sales occurred at $610.25 and $610.94 on July 2–3, near the stock's current 52-week high of $621.30; the stock has appreciated 5.6% over the past 30 days and 8.0% over 90 days. His cross-ticker track record shows a 90-day well-timed rate of 0.00% across 10 prior sells, and at SNPS specifically, all 5 measurable prior sells remain recent with no 90-day outcome data available. The absence of a 10b5-1 plan FLAG suggests discretionary timing, and the sales represent a modest reduction from a substantial retained position in a company with $1.5B quarterly revenue, +15.0% annual growth, and a 66.73 P/E ratio.

Executive Chair de Geus sells 17,078 shares (13.8% of holdings) for $10.3M at SNPS near 52-week highs

De Geus executed two separate sales totaling 17,078 shares for $10,302,620.21 on 2024-06-28 and 2024-07-01, reducing holdings from 124.1K to 107.0K shares. The blended average transaction price of $603.27 sits within the 52-week range and only 1.7% below the current 52-week high of $620.31, indicating the sales occurred at elevated valuations. Over a broader perspective, SNPS is trading near record highs with the stock up 8.7% over 30 days and 5.3% over 90 days, reflecting strong recent performance. However, the insider's cross-ticker track record shows a 0.00% well-timed sell rate across 8 prior sales, suggesting his sell timing historically has not preceded stock declines—a neutral pattern that limits confidence in predictive signal.

SNPS Executive Chair Aart de Geus sells 11,057 shares across 2 days for $6,656,974.90

De Geus sold 2 separate tranches totaling 11,057 shares (11.1K shares) for $6,656,974.90 ($6.7M), reducing his holdings by -9.4% from 118,040 shares to 106,983 shares. The sales occurred at $600.57 and $602.59 per share, blended average $602.06, slightly above the current price of $595.06. At Synopsys specifically, his prior measured sales from 2023 posted positive 90-day returns (+6.0% and +0.3%), indicating those earlier sales were poorly timed relative to subsequent price appreciation. The stock trades near the 52-week high ($620.31) at current levels, and the company maintains strong fundamentals with Revenue $1,454,712,000.00, Net income $292,107,000.00, and annual growth of +15.0%. No scheduled trading plan FLAG is disclosed in the filing facts provided, so this represents a discretionary open-market transaction.

Synopsys Executive Chair sells 6,747 shares for $4,050,911.96 at blended avg $600.40 on Jun 24-25

De Geus, as Executive Chair, executed two separate sales totaling 6,747 shares (6.7K shares) for $4,050,911.96 ($4.1M) at a blended average price of $600.40 on June 24–25, 2024, reducing his holdings from 113,730 shares to 106,983 shares (a -5.9% reduction). The sales occurred near the 52-week high ($620.31), with the current price at $598.52 now -3.5% from that peak. His prior sales at Synopsys show mixed timing: the 2023-06-21 sale achieved +7.4% 90-day return (stock rose after the sale), the 2023-06-13 sale achieved +3.2%, and the 2023-06-06 sale achieved +3.4%, with none classified as well-timed (all generated positive returns, meaning the insider sold before subsequent gains). His cross-ticker track record shows 4 prior sells averaging +4.7% 90-day return with a 0.00% well-timed rate, indicating his historical sales have not preceded downturns. The sale occurs within the context of strong fundamentals: annual revenue growth of +15.0%, a P/E of 64.29, and market cap of $91,702,895,982.36 ($91.7B).